Thomas Lad Merrill is an experienced VP of Research at Brixton Biosciences and Co-Founder of FocalCool, LLC, specializing in medical device R&D with a focus on selective hypothermia technology for acute ischemic stroke. With a background in mechanical engineering, Thomas Lad has held various positions in research and development in companies such as Pfizer, Teva Pharmaceuticals, and Abiomed. Additionally, Thomas Lad has academic experience as an Associate Professor at Rowan University in the departments of Mechanical Engineering and Biomedical Engineering.
May, 2023 - present